公开(公告)号：US20240362931A1

公开(公告)日：2024-10-31

申请号：US18556422

申请日：2022-04-20

申请人： Cipia Vision Ltd.

发明人： Itay KATZ

IPC分类号： G06V20/59 ,  A61B5/00 ,  A61B5/16 ,  A61B5/18 ,  B60Q9/00 ,  G06T7/73

CPC分类号： G06V20/597 ,  A61B5/163 ,  A61B5/18 ,  A61B5/7267 ,  B60Q9/00 ,  G06T7/73 ,  G06T2207/20081 ,  G06T2207/30201 ,  G06T2207/30268

摘要： Systems, methods, and non-transitory computer-readable media for detecting a driver's gaze direction while driving a vehicle are disclosed. At least one processor may be configured to receive image information from an image sensor, detect the vehicle driver in the image information, detect the driver's gaze direction toward a first direction in the image information, predict an amount of time it will take for the driver to shift the gaze direction toward a second direction, using information associated with the detected gaze direction of driver, and generate a message or a command based on the predicted amount of time.

公开(公告)号：US12127827B2

公开(公告)日：2024-10-29

申请号：US17635510

申请日：2019-08-28

申请人： NEC Corporation

发明人： Chenhui Huang ,  Kenichiro Fukushi

IPC分类号： A61B5/11 ,  A61B5/00 ,  A61B5/16 ,  G01P13/00

CPC分类号： A61B5/112 ,  A61B5/1121 ,  A61B5/165 ,  A61B5/7278 ,  G01P13/00

摘要： An estimation device calculates an angle formed by a tip direction of a left foot and a tip direction of a right foot. The estimation device estimates a stride width indicating an interval between heels of the left foot and the right foot, based on the angle.

公开(公告)号：US20240355480A1

公开(公告)日：2024-10-24

申请号：US18587367

申请日：2024-02-26

申请人： NEUMORA THERAPEUTICS, INC.

发明人： Yuelu LIU ,  Monika Sharma MELLEM ,  Parvez AHAMMAD ,  Humberto Andres GONZALEZ CABEZAS ,  Matthew KOLLADA

IPC分类号： G16H50/30 ,  A61B5/00 ,  A61B5/055 ,  A61B5/16 ,  G06F18/21 ,  G06F18/214 ,  G06N20/00 ,  G16H10/20 ,  G16H20/70 ,  G16H30/20 ,  G16H30/40 ,  G16H50/20 ,  G16H50/70

CPC分类号： G16H50/30 ,  A61B5/0042 ,  A61B5/055 ,  A61B5/16 ,  A61B5/7267 ,  G06F18/2148 ,  G06F18/2178 ,  G06F18/2193 ,  G06N20/00 ,  G16H10/20 ,  G16H30/20 ,  G16H30/40 ,  G16H50/20 ,  G16H50/70 ,  A61B2576/026 ,  G06V2201/031 ,  G16H20/70

摘要： A system for evaluating mental health of patients includes a memory and a control system. The memory contains executable code storing instructions for performing a method. The control system is coupled to the memory and includes one or more processors. The control system is configured to execute the machine executable code to cause the control system to perform the method: A selection of answers associated with a patient is received. The selection of answers corresponds to each question in a series of questions from mental health questionnaires. Unprocessed MRI data are received. The unprocessed MRI data correspond to a set of MRI images of a biological structure associated with the patient. The unprocessed MRI data is processed to output a set of MRI features. Using a machine learning model, the selection of answers and the set of MRI features are processed to output a mental health indication of the patient.

公开(公告)号：US12109035B2

公开(公告)日：2024-10-08

申请号：US16791797

申请日：2020-02-14

申请人： Translational Research Institute Pty Ltd as trustee for Translational Research Institute Trust

发明人： Carolyn Mountford ,  David Crompton ,  Nathan Tosh ,  Rosanna Tremewan

IPC分类号： A61B5/00 ,  A61B5/05 ,  A61B5/055 ,  A61B5/16 ,  A61B5/374 ,  A61M21/00 ,  A61N2/00 ,  A61N2/02 ,  G01R33/46 ,  G16H20/70

CPC分类号： A61B5/4076 ,  A61B5/374 ,  A61N2/006

摘要： A method and system for monitoring therapeutic interventions for treating a patient with PTSD comprises using a scanner to obtain pre-treatment neural spectroscopic data of at least one neuromarker chemical in the brain of the patient before treatment, treating the patient with at least one treatment protocol, after treatment, obtaining post-treatment neural spectroscopic data of the at least one neuromarker chemical in the brain of the patient, and comparing the results of the pre-treatment and post-treatment data to enable a determination of the effectiveness of the treatment.

公开(公告)号：US20240331567A1

公开(公告)日：2024-10-03

申请号：US18740576

申请日：2024-06-12

申请人： SYNPHNE PTE. LTD.

发明人： Subhasis BANERJI

IPC分类号： G09B19/00 ,  A61B5/00 ,  A61B5/0205 ,  A61B5/024 ,  A61B5/08 ,  A61B5/11 ,  A61B5/16 ,  A61B5/24 ,  A61B5/291 ,  A61B5/369 ,  A61B5/374 ,  A61B5/389

CPC分类号： G09B19/00 ,  A61B5/0022 ,  A61B5/0024 ,  A61B5/0205 ,  A61B5/1118 ,  A61B5/165 ,  A61B5/4854 ,  A61B5/486 ,  A61B5/02405 ,  A61B5/082 ,  A61B5/1122 ,  A61B5/168 ,  A61B5/24 ,  A61B5/291 ,  A61B5/369 ,  A61B5/374 ,  A61B5/389 ,  A61B2505/09 ,  A61B2560/0252 ,  A61B2560/0257 ,  A61B2562/0219

摘要： Disclosed is a learning model employed to treat patients with functional impairments due to psychological, mental cognitive or physical disorders or disabilities. The treatment includes accessing at which transition stage of the learning model that a subject has movement transition deficits based on the subject's bio-signals, such as brain state and muscle state signals. The movement transition deficits are addressed so that the subject can attain an upward spiral, accelerating functional recovery or development and avoid a downward spiral towards compensation and slowing down of recovery.

公开(公告)号：US20240325780A1

公开(公告)日：2024-10-03

申请号：US18734570

申请日：2024-06-05

申请人： Cognito Therapeutics, Inc.

发明人： Zachary John Hambrecht Malchano ,  Martin Warren Williams

IPC分类号： A61N5/06 ,  A61B3/113 ,  A61B5/00 ,  A61B5/024 ,  A61B5/05 ,  A61B5/16 ,  A61B5/375 ,  A61B5/377 ,  A61B5/378 ,  A61B5/38 ,  A61B5/398 ,  A61M21/00 ,  A61N1/04 ,  A61N1/05 ,  A61N1/36 ,  G02C11/00 ,  H05B47/105

CPC分类号： A61N5/0622 ,  A61B5/0036 ,  A61B5/16 ,  A61B5/377 ,  A61B5/378 ,  A61B5/38 ,  A61B5/4088 ,  A61B5/4836 ,  A61M21/00 ,  A61N1/0456 ,  A61N1/36025 ,  A61N1/36036 ,  A61N1/36082 ,  A61N1/36092 ,  A61N1/36132 ,  A61N5/0618 ,  G02C11/10 ,  H05B47/105 ,  A61B3/113 ,  A61B5/024 ,  A61B5/05 ,  A61B5/163 ,  A61B5/168 ,  A61B5/375 ,  A61B5/398 ,  A61B5/4848 ,  A61B5/6803 ,  A61M2021/0027 ,  A61M2021/0044 ,  A61M2021/0072 ,  A61M2205/3375 ,  A61N1/0551 ,  A61N2005/0626 ,  A61N2005/0627 ,  A61N2005/0629 ,  A61N2005/0648 ,  A61N2005/0652 ,  A61N2005/0659 ,  A61N2005/0661 ,  A61N2005/0662 ,  A61N2005/0663 ,  A61N2005/0667 ,  G02C2200/10

摘要： Systems and methods of the present disclosure are directed to systems and methods for treating cognitive dysfunction in a subject in need thereof. The system can include a light source and a speaker. A visual neural stimulation system provides, via the light source, visual stimulation having a first value of a first parameter. An auditory neural stimulation system provides, via the speaker, audio stimulation having a second value of the second parameter. A stimuli orchestration component selects, for a first time interval, one of the visual stimulation or the audio stimulation to vary based on a policy, selects, for the first time interval, the other of the visual stimulation or the audio stimulation to keep constant based on the policy, and provides causes the one of the visual neural stimulation system or the auditory neural stimulation system to vary the one of the visual stimulation or the audio stimulation.

公开(公告)号：US20240319789A1

公开(公告)日：2024-09-26

申请号：US18731616

申请日：2024-06-03

申请人： APPLE INC.

发明人： Richard Ignatius Punsal LOZADA ,  Anshu K. CHIMALAMARRI ,  Bryce L. SCHMIDTCHEN ,  Gregory LUTTER ,  Paul EWERS ,  Peter BURGNER ,  Thomas J. MOORE ,  Trevor J. MCINTYRE

IPC分类号： G06F3/01 ,  A61B5/16

CPC分类号： G06F3/013 ,  A61B5/163

摘要： Various implementations disclosed herein include devices, systems, and methods that determine whether the user is reading text or intends an interaction with a portion of the text in order to initiate an interaction event during the presentation of the content. For example, an example process may include obtaining physiological data associated with an eye of a user during presentation of content, wherein the content includes text, determining whether the user is reading a portion of the text or intends an interaction with the portion of the text based on an assessment of the physiological data with respect to a reading characteristic, and in accordance with a determination that the user intends the interaction with the portion of the text, initiating an interaction event associated with the portion of the text.

公开(公告)号：US12097031B2

公开(公告)日：2024-09-24

申请号：US18278003

申请日：2021-03-15

申请人： Mitsubishi Electric Corporation

发明人： Seiro Yuge ,  Kota Kurihara ,  Koji Ota ,  Noriko Nagata ,  Masashi Sugimoto ,  Fan Zhang

IPC分类号： A61B5/16 ,  A61B5/00 ,  A61B5/01 ,  A61B5/0533 ,  A61B5/332 ,  A61B5/346

CPC分类号： A61B5/165 ,  A61B5/0075 ,  A61B5/01 ,  A61B5/0533 ,  A61B5/332 ,  A61B5/346 ,  A61B5/7278

摘要： An emotion estimation apparatus includes preparation biological information acquisition circuitry acquires, separately from subjects who are in a preparation space, first biological information indicating a physical state of each subject and analyzes the first biological information, preparation emotion information acquisition circuitry acquires emotion information indicating an emotion of each of the subjects, association construction circuitry constructs association information in which the first biological information and the emotion information corresponding to the first biological information are associated with each other, estimation biological information acquisition circuitry acquires second biological information indicating a physical state of any one subject of the subjects who is present in an estimation space, estimation circuitry extracts the emotion information associated in the association information with the first biological information that is equal to the second biological information, and estimate an emotion of the one subject according to the emotion information thus extracted.

公开(公告)号：US20240312619A1

公开(公告)日：2024-09-19

申请号：US18669103

申请日：2024-05-20

申请人： KC HOLDINGS I

发明人： Robert Louis Kaleal, III

IPC分类号： G16H40/63 ,  A61B5/00 ,  A61B5/0205 ,  A61B5/08 ,  A61B5/11 ,  A61B5/16 ,  A61B5/20 ,  G06F1/16 ,  G06Q10/0639 ,  G06Q10/10 ,  G06Q50/00 ,  G06T13/40 ,  G06T19/00 ,  G09B5/02 ,  G09B5/06 ,  G09B19/00 ,  G16H20/40 ,  G16H20/70

CPC分类号： G16H40/63 ,  A61B5/0205 ,  A61B5/02055 ,  A61B5/11 ,  A61B5/165 ,  A61B5/20 ,  A61B5/40 ,  A61B5/41 ,  A61B5/42 ,  A61B5/43 ,  A61B5/45 ,  A61B5/486 ,  A61B5/7264 ,  A61B5/744 ,  A61B5/7445 ,  G06F1/1626 ,  G06Q10/0639 ,  G06Q10/10 ,  G06Q50/01 ,  G06T13/40 ,  G06T19/00 ,  G09B5/02 ,  G09B5/06 ,  G09B19/00 ,  G09B19/0092 ,  G16H20/40 ,  G16H20/70 ,  A61B5/08 ,  A61B5/44 ,  A61B5/7246 ,  G06T2219/2012

摘要： Systems and methods are disclosed that facilitate providing guidance to a user during performance of a program or routine using a personalized avatar. In an aspect, a system includes a reception component configured to receive biochemical information about a physiological state or condition of a user, including information identifying a presence or a status of one or more biomarkers. The system further includes an analysis component configured to determine or infer one or more characteristics of the physiological state or condition of the user based on the information identifying the presence or the status of the one or more biomarkers, and a visualization component configured to adapt an appearance of an avatar presented to the user based on the one or more characteristics to reflect the one or more characteristics.

公开(公告)号：US20240307651A1

公开(公告)日：2024-09-19

申请号：US18573098

申请日：2022-10-21

申请人： Innsightful, Inc.

发明人： Farzad Ehsani

IPC分类号： A61M21/00 ,  A61B5/0531 ,  A61B5/16

CPC分类号： A61M21/00 ,  A61B5/0531 ,  A61B5/165 ,  A61M2021/0027 ,  A61M2021/005

摘要： A device, system, and method for assessing and managing resilience of an individual, particularly in regard to levels of stress, anxiety, and hardship the individual is capable of handling. A system is configured to evaluate physiological data of the individual and to estimate a resilience of the individual based on the evaluation. The resilience may relate to an ability of the individual to manage, or not manage, a stressor based on one or more resilience parameters. The system may intervene to help the individual improve their resilience, for example, if the individual has not coped with and/or recovered from a past stressor, is not coping with and/or recovering from a current stressor, and/or is not prepared to cope with and/or recover from a future stressor.